SFDA crackdown to get house in order
The Chinese State Food and Drug Administration (SFDA) has revealed plans to tighten the drug registration review process as it attempts to improve standards in the nation.
Archives for May 14, 2008
Agilent announces second expansion at API plant
Agilent Technologies is expanding its nucleic acid active pharmaceutical ingredient (API) manufacturing facility in Boulder, Colorado, US, as the industry gravitates towards the development of oligonucleotide-based drugs.
Bushu business booming as Japan outsourcing roused
Bushu Pharmaceuticals, Japan's largest dedicated contract manufacturer, has been going from strength to strength as Japan's pharma outsourcing industry awakens.